EUVIMEDEUVIMED entdecken
Crossref

Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease

Aya Kawaguchi, Jun Akiba, Sachiko Ogasawara, Reiichiro Kondo, Yoshiki Naito, Hironori Kusano, Sakiko Sanada, Ikko Muto, Takekuni Nakama, Hirohisa Yano

Pathology - Research and Practice · 2023

DOI: 10.1016/j.prp.2023.154309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Aya Kawaguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; Department of Dermatology, Kurume University School of Medicin…. Hauptthemen laut MEDLINE: Paget Disease, Extramammary, Skin Neoplasms, Transcription Factor AP-2. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Extramammary Paget's disease (EMPD) is a slowly advancing malignancy that sometimes progresses to the invasion of the dermis, systemic metastases, and death. Although there have been reports that dermal invasion is associated with poor prognosis, no molecular markers of this invasion have been identified thus far. The aim of this study was to identify key molecules for predicting the risk of EMPD dermis invasion. METHOD: We performed microarray screening for three cases of in-situ EMPDs, three cases of invasive EMPDs, and three cases of normal epidermis. We identified a molecule that exhibited a stepwise increase in expression. Further, we analyzed 47 cases of EMPD using immunohistochemical staining (IHC) and examined the correlated clinicopathological findings, including prognosis. RESULT: We examined molecules that showed stepwise differences with invasion. We focused on transcription factor activating enhancer-binding protein 2 B (TFAP2B). Of the 47 EMPD patients, 38 (80.9 %) and 9 (19.1 %) had low and high TFAP2B expression, respectively. TFAP2B expression was significantly correlated with invasion into the dermis, mass formation, and preoperative lymph node metastasis (p = 0.001, 0.042, and 0.033, respectively). The cumulative postoperative recurrence-free rate in the TFAP2B-high expression group was significantly lower than that in the TFAP2B-low expression group (P < 0.001). In univariate analysis of recurrence-free survival, TFAP2B expression was found to be a significant factor (p = 0.006). CONCLUSION: The expression of TFAP2B, which was comprehensively found by microarray screening, may correlate with the invasiveness of EMPD and may be an unfavorable prognostic factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paget Disease, ExtramammarySkin NeoplasmsTranscription Factor AP-2HumansLymphatic MetastasisPrognosisStaining and Labeling

Stichwörter der Autor:innen

Extramammary Paget`s diseaseInvasivenessPrognosisTFAP2B

Substanzen

TFAP2B protein, humanTranscription Factor AP-2

Autor:innen und Institutionen

  • Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan. Electronic address: nanri_aya@kurume-u.ac.j…
  • Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka, Japan.
  • Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Department of Clinical Laboratory Medicine, Kurume University Hospital, Kurume, Fukuoka, Japan.
  • Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; Department of Clinical Laboratory, National Hospital Organization Kokura Medical Center, Kitakyushu, Fukuoka, Japan.
  • Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kawaguchi, A., Akiba, J., Ogasawara, S., Kondo, R., Naito, Y., Kusano, H., Sanada, S., Muto, I., Nakama, T., & Yano, H. (2023). Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154309

Vancouver

Kawaguchi A, Akiba J, Ogasawara S, Kondo R, Naito Y, Kusano H, et al. Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154309

BibTeX
@article{Kawaguchi2023,
  author = {Kawaguchi, Aya and Akiba, Jun and Ogasawara, Sachiko and Kondo, Reiichiro and Naito, Yoshiki and Kusano, Hironori and Sanada, Sakiko and Muto, Ikko and Nakama, Takekuni and Yano, Hirohisa},
  title = {Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease},
  journal = {Pathology - Research and Practice},
  year = {2023},
  doi = {10.1016/j.prp.2023.154309}
}
Kostenlos starten →